- $1.76bn
- $1.92bn
- $2.82bn
- 61
- 81
- 91
- 92
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 7.86 | ||
| PEG Ratio (f) | 0.22 | ||
| EPS Growth (f) | 56.39% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.01 | ||
| Price to Tang. Book | 1.1 | ||
| Price to Free Cashflow | 23.53 | ||
| Price to Sales | 0.62 | ||
| EV to EBITDA | 3.7 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 4.04% | ||
| Return on Equity | 8.7% | ||
| Operating Margin | 17.98% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 889.79 | 2,130.3 | 2,105.6 | 2,706.6 | 2,817.7 | 2,524 | 2,670 | 23.45% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -29.02 | -94.85 | n/a | n/a | -47.95 | +92.36 | +16.25 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
SiriusPoint Ltd. is a Bermuda-based global underwriter of insurance and reinsurance providing solutions to clients and brokers around the world. The Company has licenses to write property and casualty and accident and health insurance and reinsurance globally. The Company’s segments include Reinsurance and Insurance & Services. In the Reinsurance segment, the Company provides reinsurance products to insurance and reinsurance companies, government entities, and other risk-bearing vehicles on a treaty or facultative basis. The Reinsurance segment predominantly underwrites casualty, property and specialty lines of business on a worldwide basis. For reinsurance assumed, it participates in the reinsurance market with a global focus through the broker market distribution channel. Through the Insurance & Services segment, the Company underwrites primary insurance in a number of sectors. The Insurance & Services segment includes accident and health, casualty, and specialty.
Directors
- Siddhartha Sankaran CHM (43)
- David Junius CFO (50)
- David Govrin CEX (57)
- Monica Manhem CEX (61)
- Prashanth Gangu COO (41)
- Vievette Henry CHO (57)
- Larry Hallett SVP
- Christopher Coleman CAO (46)
- Ming Zhang CIN (39)
- Jeffrey Davis CRO (56)
- Rachael Dugan GCN (40)
- Rafe De La Gueronniere LED (68)
- Joshua Targoff LED (51)
- Sharon Ludlow DRC
- Wei Han Tan DRC (48)
- Gretchen Hayes IND (65)
- Mehdi Mahmud IND (47)
- Franklin Montross IND (65)
- Mark Parkin IND (69)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- October 6th, 2011
- Public Since
- August 15th, 2013
- No. of Shareholders
- 278
- No. of Employees
- 1,072
- Sector
- Insurance
- Industry
- Financials
- Exchange
New York Stock Exchange- Shares in Issue
- 106,253,887
- Address
- POINT BUILDING, 3 WATERLOO LANE, PEMBROKE, HM 08
- Web
- https://www.siriuspt.com/
- Phone
- +1 4415423300
- Auditors
- PricewaterhouseCoopers LLP
Latest News for SPNT
Upcoming Events for SPNT
Q1 2025 Siriuspoint Ltd Earnings Release
Q1 2025 Siriuspoint Ltd Earnings Call
Siriuspoint Ltd Annual Shareholders Meeting
Siriuspoint Ltd Annual Shareholders Meeting
Q2 2025 Siriuspoint Ltd Earnings Release
Similar to SPNT
Aegon
New York Stock Exchange
Aflac
New York Stock Exchange
Allstate
New York Stock Exchange
Ambac Financial
New York Stock Exchange
American Financial
New York Stock Exchange
FAQ
As of Today at 23:17 UTC, shares in Siriuspoint are trading at $16.54. This share price information is delayed by 15 minutes.
Shares in Siriuspoint last closed at $16.54 and the price had moved by +39.11% over the past 365 days. In terms of relative price strength the Siriuspoint share price has outperformed the S&P500 Index by +28.4% over the past year.
The overall consensus recommendation for Siriuspoint is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreSiriuspoint does not currently pay a dividend.
Siriuspoint does not currently pay a dividend.
Siriuspoint does not currently pay a dividend.
To buy shares in Siriuspoint you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $16.54, shares in Siriuspoint had a market capitalisation of $1.76bn.
Here are the trading details for Siriuspoint:
- Country of listing: United States
- Exchange: NYQ
- Ticker Symbol: SPNT
Based on an overall assessment of its quality, value and momentum Siriuspoint is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Siriuspoint is $17.00. That is 2.78% above the last closing price of $16.54.
Analysts covering Siriuspoint currently have a consensus Earnings Per Share (EPS) forecast of $2.00 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Siriuspoint. Over the past six months, its share price has outperformed the S&P500 Index by +29.32%.
As of the last closing price of $16.54, shares in Siriuspoint were trading +12.66% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Siriuspoint PE ratio based on its reported earnings over the past 12 months is 7.86. The shares last closed at $16.54.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Siriuspoint's management team is headed by:
- Siddhartha Sankaran - CHM
- David Junius - CFO
- David Govrin - CEX
- Monica Manhem - CEX
- Prashanth Gangu - COO
- Vievette Henry - CHO
- Larry Hallett - SVP
- Christopher Coleman - CAO
- Ming Zhang - CIN
- Jeffrey Davis - CRO
- Rachael Dugan - GCN
- Rafe De La Gueronniere - LED
- Joshua Targoff - LED
- Sharon Ludlow - DRC
- Wei Han Tan - DRC
- Gretchen Hayes - IND
- Mehdi Mahmud - IND
- Franklin Montross - IND
- Mark Parkin - IND